title: Comparative bioavailability of two oral formulations manufactured in Mexico containing glyburide and metformin in diabetic patients.
authors.affiliation: fjfloresmurrieta@prodigy.net.mx
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: Flores-Murrieta
authors.forename: María E
authors.initials: ME
authors.lastname: Aguilar-Cota
authors.forename: Angélica
authors.initials: A
authors.lastname: Camacho
authors.forename: Gerardo
authors.initials: G
authors.lastname: Reyes-García
authors.forename: Jorge E
authors.initials: JE
authors.lastname: Herrera
authors.forename: Roberto
authors.initials: R
authors.lastname: Medina-Santillán
mesh_terms: D000368:Aged; D019540:Area Under Curve; D001682:Biological Availability; D002626:Chemistry, Pharmaceutical; D002851:Chromatography, High Pressure Liquid; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000378:metabolism*; D005260:Female; D005905:Glyburide / Q000493:pharmacokinetics*; D006207:Half-Life; D006801:Humans; D007004:Hypoglycemic Agents / Q000493:pharmacokinetics*; D008687:Metformin / Q000493:pharmacokinetics*; D008800:Mexico; D013056:Spectrophotometry, Ultraviolet; D013607:Tablets
chemical_list: D007004:Hypoglycemic Agents; D013607:Tablets; D008687:Metformin; D005905:Glyburide